It is important to highlight that in the context of diseases associated with hemolysis, such as sickle cell anemia, sepsis, transfusion reactions, and subarachnoid hemorrhage, hemoglobin itself acts as a critical pathogenic factor, and these conditions often exhibit haptoglobin depletion and respond well to haptoglobin supplementation (19–22). This evidence concerns the gene HP and sickle cell disease.